Bupropion for depression in schizophrenia

Clinical Neuropharmacology

Volumn 33, Issue 5, 2010, Pages 257-259

  Englisch, Susanne ^a   Inta, Dragos ^a   Eßer, Andrea ^a   Zink, Mathias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

antidepressant; antipsychotic; bupropion; depression; schizophrenia

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMISULPRIDE; ARIPIPRAZOLE; CLONAZEPAM; OLANZAPINE; PROMETHAZINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MALE; MENTAL DISEASE; NEUROTRANSMISSION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOMETRY; SCHIZOPHRENIA; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL DISORDER; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BUPROPION; DEPRESSION; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77958014626     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181f5a5f9     Document Type: Article

References (18)

1. An der Heiden W, Könnecke R, Maurer K, et al. Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2005;255:174Y184.
2. Palmer BA, Pankratz S, Bostwick JM. The lifetime risk of suicide in schizophrenia. Arch Gen Psychiatry 2005;62:247Y253.
3. Conley RR, Ascher-Svanum H, Zhu B, et al. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res 2007;90:186Y197.
4. Whitehead C, Moss S, Cardno A, et al. Antidepressants for the treatment of depression in people with schizophrenia: a systematic review. Psychol Med 2003;33(4):589Y599.
5. Rummel C, Kissling W, Leucht S. Antidepressants for the negative symptoms of schizophrenia. Cochr Datab Syst Rev 2006;3:CD005581.
6. Zink M, Englisch S, Meyer-Lindenberg A. Polypharmacy in schizophrenia. Curr Opin Psychiatry 2010;23(2):103Y111.
7. Nutt D, Demyttenaere K, Janka Z, et al. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. J Psychopharmacol 2007;21(5):461Y471.
8. Dwoskin LP, Rauhut AS, King-Pospisil KA, et al. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 2006;12(3Y4):178Y207.
9. Howard WT, Warnock JK. Bupropion-induced psychosis. Am J Psychiatry 1999;156(12):2017Y2018.
10. Johnston JA, Lineberry CG, Frieden CS. Prevalence of psychosis, delusions, and hallucinations in clinical trials with bupropion. Am J Psychiatry 1986;143(9):1192Y1193.
11. Javelot H, Baratta A, Weiner L, et al. Two acute psychotic episodes after administration of bupropion: a case of involuntary rechallenge. Pharm World Sci 2009;31(2):238Y240.
12. Dufresne RL, Kass DJ, Becker RE. Bupropion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia. Drug Develop Res 1988;12(3Y4):259Y266.
13. Goode DJ, Manning AA. Comparison of bupropion alone and with haloperidol in schizo-affective disorder, depressed type. J Clin Psychiatry 1983;44(7):253Y255.
14. Evins AE, Cather C, Deckersbach T, et al. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. J Clin Psychopharmacol 2005;25(3):218Y225.
15. Fatemi SH, Stary JM, Hatsukami DK, et al. A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia. Schizophr Res 2005;76(2Y3):353Y356.
16. George TP, Vessicchio JC, Termine A, et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 2002;52(1):53Y61.
17. Englisch S, Knopf U, Scharnholz B, et al. Duloxetine for major depressive episodes in the course of psychotic disorders: An observational clinical trial. J Psychopharmacol 2009;23:875Y882.
18. Bergmann F, Bleich S, Wischer S, et al. Seizure and cardiac arrest during bupropion SR treatment. J Clin Psychopharmacol 2002;22(6):630Y631.